1-(cyclohexylmethyl)-2-methoxybenzene | 92300-32-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: 1-(cyclohexylmethyl)-2-methoxybenzene
• 英文别名: 2-Hexahydrobenzyl-anisol；α-Cyclohexyl-2-methoxy-toluol
• CAS: 92300-32-8
• 化学式: C₁₄H₂₀O
• 分子量: 204.312
• InChiKey: QBUWFARJLZGFSJ-UHFFFAOYSA-N

物化性质

• 沸点：
  289.6±9.0 °C(Predicted)
• 密度：
  0.978±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  5.4
• 重原子数：
  15
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.57
• 拓扑面积：
  9.2
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  1-(cyclohexylmethyl)-2-methoxybenzene 在 三溴化硼 作用下， 以 二氯甲烷 为溶剂， 以95%的产率得到2-(cyclohexylmethyl)phenol
  参考文献：
  名称：

  4,4′-Unsymmetrically substituted 3,3′-biphenyl alpha helical proteomimetics as potential coactivator binding inhibitors

  摘要：

  A series of unsymmetrically substituted biphenyl compounds was designed as alpha helical proteomimetics with the aim of inhibiting the binding of coactivator proteins to the nuclear hormone receptor coactivator binding domain. These compounds were synthesized in good overall yields in seven steps starting from 2-bromoanisole. The final products were evaluated using cotransfection reporter gene assays and mammalian two-hybrid competitive inhibition assays to demonstrate their effectiveness as competitive binding inhibitors. The results from this study indicate that these proteomimetics possess the ability to inhibit coactivator-receptor interactions, but via a mixed mode of inhibition. (C) 2013 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2013.10.051
• 作为产物：
  描述：

  溴代环己烷 在 palladium on activated charcoal 氢气 作用下， 以 乙醇 、 水 为溶剂， 40.0 ℃ 、344.73 kPa 条件下， 反应 20.0h， 生成 1-(cyclohexylmethyl)-2-methoxybenzene
  参考文献：
  名称：

  Thyroid hormone analogs. Synthesis of 3'-substituted 3,5-diiodo-L-thyronines and quantitative structure-activity studies of in vitro and in vivo thyromimetic activities in rat liver and heart

  摘要：

  Twenty-nine novel 3'-substituted derivatives of the thyroid hormone 3,3',5-triiodo-L-thyronine (T3) have been synthesized by using established methods and by a new route involving manipulation of a 3'-formyl intermediate. In vitro hormone receptor binding (to intact nuclei) and in vivo thyromimetic activity (induction of mitochondrial 3-phosphoglycerate oxidoreductase, GPDH) were measured in rat liver and heart for these new analogues and for the 18 previously reported 3'-substituted 3,5-diiodo-L-thyronines. Analysis of the binding data using theoretical conformational and quantitative structure-affinity methods implies that the 3'-substituent recognition site on the thyroid hormone receptor is hydrophobic and limited in depth to the length of the natural iodo substituent, but has sufficient width to accommodate a phenyl or cyclohexyl group. Receptor binding is reduced by approximately 10-fold in 3'-acyl derivatives which form strong intramolecular acceptor hydrogen bonds with the adjacent 4'-hydroxyl. The compounds studied showed no differences in their relative affinities for heart and liver nuclei, suggesting that receptors in these tissues are similar. However, the relationships between thyromimetic activity (induction of GPDH) and nuclear binding showed some tissue differences. A high correlation between activity and binding is observed for full agonists in the heart, but an equally significant correlation for the liver data is only seen when 3'-substituent bulk (molar refractivity) is included in the analysis. These results suggest the possibility that differential tissue penetration or access to receptors may occur in vivo.

  DOI：

  10.1021/jm00396a008

文献信息

• Copper-catalyzed sp3-sp3 cross-coupling of turbo grignards with benzyl halides
  作者：Greg Petruncio、Synah Elahi-Mohassel、Michael Girgis、Mikell Paige

  DOI：10.1016/j.tetlet.2021.153516

  日期：2021.12

  benzyl halides and sulfonates imparts unique reactivity at the benzylic carbon atom. Photoredox sp3-sp3 cross-coupling proved ineffective for coupling p-methoxybenzyl chloride (PMBCl), leading to a new strategy for the sp3-sp3 cross-coupling of benzyl halides and sulfonates. This strategy involved LiCl-accelerated synthesis of a Grignard reagent followed by a copper-catalyzed cross-coupling. The conditions

  苄基卤化物和磺酸盐中的芳环赋予苄基碳原子独特的反应性。Photoredox sp 3 -sp 3交叉偶联被证明对偶联对甲氧基苄基氯 (PMBCl)无效，导致了苄基卤化物和磺酸盐的 sp 3 -sp 3交叉偶联的新策略。该策略涉及 LiCl 加速格氏试剂的合成，然后是铜催化的交叉偶联。由于 PMBCl 的特殊反应性，该条件对 PMBCl 工作良好，但其他苄基溴或磺酸盐反应不佳。
• Cobalt-catalyzed cross-coupling of Umpolung carbonyls with alkyl halides under mild conditions
  作者：Ruofei Cheng、Graham de Ruiter、Chao-Jun Li

  DOI：10.1039/d2cc04302e

  日期：——

  dominated by palladium and nickel catalysts, cobalt-based catalysts have shown unique advantages for such cross-coupling reactions in terms of higher catalytic activity and lower toxicity. Herein, we describe a novel cobalt-catalyzed alkyl–alkyl cross-coupling reaction of hydrazone with alkyl halides under mild reaction conditions, where the use of a PNP-type pincer ligand is essential for catalysis

  虽然经典的交叉偶联以钯和镍催化剂为主，但钴基催化剂在这种交叉偶联反应中表现出独特的优势，即更高的催化活性和更低的毒性。在此，我们描述了一种新型钴催化的腙与卤代烷在温和反应条件下的烷基-烷基交叉偶联反应，其中使用 PNP 型钳形配体对催化至关重要。醛和酮腙都与该反应相容，以中等至良好的产率产生一系列 C(sp 3 )–C(sp 3 ) 偶联产物。
• 57. Alkylation of the aromatic nucleus. Part VIII. Benzylation and cyclohexylmethylation
  作者：J. Blackwell、W. J. Hickinbottom

  DOI：10.1039/jr9630000366

  日期：——
• LEESON, PAUL D.;ELLIS, DAVID;EMMETT, JOHN C.;SHAH, VIRENDRA P.;SHOWELL, G+, J. MED. CHEM., 31,(1988) N 1, 37-54
  作者：LEESON, PAUL D.、ELLIS, DAVID、EMMETT, JOHN C.、SHAH, VIRENDRA P.、SHOWELL, G+

  DOI：——

  日期：——
• Thyroid hormone analogs. Synthesis of 3'-substituted 3,5-diiodo-L-thyronines and quantitative structure-activity studies of in vitro and in vivo thyromimetic activities in rat liver and heart
  作者：Paul D. Leeson、David Ellis、John C. Emmett、Virendra P. Shah、Graham A. Showell、Anthony H. Underwood

  DOI：10.1021/jm00396a008

  日期：1988.1

  Twenty-nine novel 3'-substituted derivatives of the thyroid hormone 3,3',5-triiodo-L-thyronine (T3) have been synthesized by using established methods and by a new route involving manipulation of a 3'-formyl intermediate. In vitro hormone receptor binding (to intact nuclei) and in vivo thyromimetic activity (induction of mitochondrial 3-phosphoglycerate oxidoreductase, GPDH) were measured in rat liver and heart for these new analogues and for the 18 previously reported 3'-substituted 3,5-diiodo-L-thyronines. Analysis of the binding data using theoretical conformational and quantitative structure-affinity methods implies that the 3'-substituent recognition site on the thyroid hormone receptor is hydrophobic and limited in depth to the length of the natural iodo substituent, but has sufficient width to accommodate a phenyl or cyclohexyl group. Receptor binding is reduced by approximately 10-fold in 3'-acyl derivatives which form strong intramolecular acceptor hydrogen bonds with the adjacent 4'-hydroxyl. The compounds studied showed no differences in their relative affinities for heart and liver nuclei, suggesting that receptors in these tissues are similar. However, the relationships between thyromimetic activity (induction of GPDH) and nuclear binding showed some tissue differences. A high correlation between activity and binding is observed for full agonists in the heart, but an equally significant correlation for the liver data is only seen when 3'-substituent bulk (molar refractivity) is included in the analysis. These results suggest the possibility that differential tissue penetration or access to receptors may occur in vivo.